Y-mAbs Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
10.50
|
|
Average Rating
|
3.56
|
|
# Strong Buys
|
2
|
|
# Buys
|
2
|
|
# Holds
|
4
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.71
|
-0.63
|
0.08
|
11.27%
|
|
2022-06-30
|
-0.67
|
-0.94
|
-0.27
|
-40.30%
|
|
2022-03-31
|
-0.72
|
-0.64
|
0.08
|
11.11%
|
|
2021-12-31
|
-0.70
|
-0.85
|
-0.15
|
-21.43%
|
|
2021-09-30
|
-0.60
|
-0.66
|
-0.06
|
-10.00%
|
|
2021-06-30
|
-0.67
|
-0.53
|
0.14
|
20.90%
|
|
2021-03-31
|
0.19
|
0.75
|
0.56
|
294.74%
|
|
2020-12-31
|
-0.51
|
-0.48
|
0.03
|
5.88%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.21
|
|
2021-12-31
|
-1.29
|
|
2020-12-31
|
-2.97
|
|
2019-12-31
|
-2.30
|
|
2018-12-31
|
-1.29
|